Why the study?
Does treatment with potent antihypertensive drugs improve survival in patients with malignant hypertension?
Population
84 patients with malignant hypertension
Comparison
Potent antihypertensive drugs vs Untreated historical series
Design
Cohort
Follow-up
up to 6 years
Authors
Loading...
Antihypertensive treatment may improve survival in malignant hypertension; leaves open confirmation in randomized trials.
Does treatment with potent antihypertensive drugs improve survival in patients with malignant hypertension?
Long-term treatment of malignant hypertension with potent antihypertensive drugs substantially improves survival compared to historical untreated cohorts.
Dustan et al. (1958) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: